Trump’s 2025 tariff policy initially exempted certain goods, like pharmaceuticals and semiconductors, from the 10% baseline and reciprocal tariffs. The administration aims to protect U.S. industries, but debates persist over whether exemptions undermine the strategy or prevent shortages and price spikes worldwide.
@ISIDEWITH2 týdny2W
No, exemptions weaken the goal of reshoring manufacturing
@ISIDEWITH2 týdny2W
No, all imports should face tariffs to ensure fair competition
@ISIDEWITH2 týdny2W
Yes, but review exemptions annually to encourage domestic production
@ISIDEWITH2 týdny2W
Yes, and extend exemptions to all critical supply chain items